韓國韓醫藥育成發展綜合計畫發展概況

The Summary of Comprehensive Plan to Foster Korean Medicine and Pharmaceutics

2003年韓國公告《韓醫藥育成法》奠定五年一期之韓醫藥育成發展綜合計畫（以下簡稱綜合計畫）法源基礎，且透過《韓醫藥育成法施行法令》完善韓醫藥育成發展審議委員會之職權，自2006年起韓國保健福祉部已執行三期綜合計畫，並於2021年公布第四期綜合計畫。
第一期至第三期綜合計畫內容逐步完善韓醫藥法規架構、建立基礎建設、奠定政策基礎及體系，且韓醫藥醫療、韓藥品質、韓醫藥產業、韓醫藥研發、韓醫藥國際競爭力等各領域皆有多項成果。韓醫藥醫療成果主要包含建立韓醫藥基礎建設、提升韓醫醫療科學性及可信度、加強韓醫藥服務品質及保障性，以及提升韓醫藥功能及角色；韓藥品質成果主要包含完善韓藥標準及法規、提升韓藥流通，以及韓藥材栽培及資源保護；韓醫藥產業成果主要包含協助地方政府發展地方韓醫藥產業群集，以及建立及擴大韓醫藥廣域群集；韓醫藥研發成果主要包含保健福祉部、科學技術情報通信部以及韓醫學研究院韓醫藥研發，以及各韓醫藥研究中心支援；韓醫藥國際競爭力成果主要包含提升韓醫藥振興院組織功能、韓醫藥知識資訊化、提升韓醫藥國際交流。
第四期綜合計畫以「促進以韓醫藥為中心之地方健康福祉」、「改善韓醫藥醫療利用體系」、「韓醫藥產業創新成長」、「提升韓醫藥全球競爭力」為四大目標，透過加強韓醫藥基層醫療及公共衛生服務，擴大韓醫藥保障範圍，強化韓藥全週期安全管理體系，加強韓醫藥於慢性病、高齡疾病、新興傳染疾病研究，支援韓醫藥大數據和人工智慧研發，建立韓醫藥全球網路等措施發展目標。
依據綜合計畫之成果，建議參考過去韓醫藥發展預算規劃臺灣中醫藥發展經費，建立完善臺灣中醫藥數據統計體系，研究與分析韓醫藥基礎建設（如：傳統醫學資訊網站）、韓醫藥標準（如：GAP標準栽培手冊）、韓醫藥特色措施（如：韓醫藥產業群集）等多項成果，以及第四期綜合計畫韓醫藥居家照顧服務、優良韓藥、韓藥安全性評估及副作用監測、院內及院外湯煎室管理、韓醫藥創新技術開發項目等多項政策，以建立符合臺灣中醫藥發展現況及需求之中長期計畫。

In 2003, South Korea promulgated the '' Korean Medicine and Pharmaceutics Promotion Act '' which laid the foundation of law for the five-year '' Comprehensive Plan to Foster Korean Medicine and Pharmaceutics (hereinafter referred to as the ''Comprehensive Plan'')'', and completed the administration of ''Korean Medicine and Pharmaceutics Development Deliberation Committee '' through the '' Korean Medicine and Pharmaceutics Promotion Enforcement Decree''. Since 2006, the Ministry of Health and Welfare of South Korea has implemented three phases of the Comprehensive Plan, and announced the fourth phase of the Comprehensive Plan in 2021. In 2003, South Korea promulgated the ''Korean Medicine and Pharmaceutics Promotion Act ''which laid the foundation of law for the five-year ''Comprehensive Plan to Foster Korean Medicine and Pharmaceutics (hereinafter referred to as the ''Comprehensive Plan'')'', and completed the administration of ''Korean Medicine and Pharmaceutics Development Deliberation Committee ''through the ''Korean Medicine and Pharmaceutics Promotion Enforcement Decree''. Since 2006, the Ministry of Health and Welfare of South Korea has implemented three phases of the Comprehensive Plan, and announced the fourth phase of the Comprehensive Plan in 2021.
The first to third phases of the Comprehensive Plan gradually improved the legal framework of Korean medicine and pharmaceutics (hereinafter referred to as''KMP''), established infrastructure, and laid foundation and system of policy. And many achievements in Korean medical services, Herbal medicine quality, KMP industry, KMP research and development, KMP international competitiveness have completed. The achievements in Korean medical services mainly include the establishment of the basic construction, the improvement of the scientific and credibility, the enhancement of quality and indemnificatory of Korean medical services, and the enhancement of the functions and roles of the KMP. The achievements in herbal medicine quality mainly include the improvement of the standards and regulations, the enhancement of distrubtion system of herbal medicine, the cultivation and protection of herbal preparations. The achievements in KMP industry mainly include assisting local governments to develop local KMP industry clusters, and the establishment and expansion of KMP wide-area clusters. The achievements in KMP research and development mainly include the researches of the Ministry of Health and Welfare, the Ministry of Science and ICT, Korea Institute of Oriental Medicine, and the support of KMP research centers. The achievements in KMP international competitiveness mainly include the improvement of the organization function of the ''National Institute for Korean Medicine Development'', the informationization of KMP knowledge, and the promotion of the international exchange of KMP.
The fourth phase of the Comprehensive Plan has four goals: ''Promoting the health and well-being of local areas based on KMP'', ''Improving the medical utilization system of KMP'', ''Innovating of the KMP industry'', and ''Improving the global competitiveness of KMP''. By strengthening the primary medical and public health services of Korean medicine, expanding KMP coverage, strengthening the life-cycle risk management system of Korean Pharmaceutics, strengthening the research of KMP in chronic diseases, aging-associated diseases, and emerging infectious diseases, supporting big data and artificial intelligence research and development in KMP, establishing aglobal network of KMP and other measures to develop Comprehensive Plan goal.
According to the results of the Comprehensive Plan, it is recommended to refer to the KMP development past budgets for Taiwan’s Chinese medicine and pharmacy (hereinafter referred to as''TMP'') development funds, establish and improve TMP statistics system, research and analyze the KMP development achievements which including KMP infrastructure (e.g. Oriental Medicine Advanced Searching Integrated System), KMP standards (e.g GAP standard cultivation techniques in medicinal crops), and special measures of KMP (e.g KMP industry cluster). And the fourth phase of the Comprehensive Plan will develop policies such as KMP home health care, premium herb, herbal medicine safety assessment and side-effect monitoring, hospital and out-of-hospital decoction room management, KMP innovative technology development projects, etc. It is recommended that research relevant results and policy to establish the medium-term and long-term plans which meets the current situation and development needs of TMP.
This case presents a64-year-old male with hydrocele caused by heart failure successfully treated with combination of Chinese and Western medicine. He was admitted to Kaohsiung Municipal Ta-Tung Hospital due to heart failure related with pulmonary edema, and was discharged after treatment one month ago. He was again admitted to the emergency department of Kaohsiung Municipal Ta-Tung Hospital 10 days ago due to sudden onset of hydrocele and bilateral lower limb edema after consuming alarge amount of ice cold beverages, and he was diagnoses as (1) heart failure (2) edema (scrotum and lower limbs). After treated with diuretics, lower limb edema was completely alleviated, while hydrocele was remitted by half. However, he suffered from chest tightness, dyspnea, and hypodynamia, which might be the side effects of previous treatments. He thus seeked for Chinese medicine treatment. According to traditional Chinese medicine pattern identification, he is recognized as cold fluid retention and heart-spleen-kidney yang deficiency and is diagnosis as“hydrocele”at the same time. The traditional Chinese medicine prescriptions are Zhen-Wu Tang and Ba-Wei-Di-Huang Wan with modification. After one-week treatment, the patient reached near-complete symptom remission. And the hydrocele with 10% left after 3weeks. His condition was well-controlled without relapse in five-month follow-ups by telephone interview.
The International Classification of Diseases is astandardized system that categorizes existing diseases. In 2008, The World Health Organization decided to include Traditional Medicine in Chapter 26,“Supplementary Chapter Traditional Medicine Conditions”, of ICD-11. This article provides acomprehensive introduction to this ICD chapter, and further analyzes future influences it can have in the field of Chinese medicine in Taiwan through the integration of various research regarding terminology and disease classification, so that the medical field in Taiwan can implement this system to clinical and research purposes more efficiently once it is applicable.
After COVID-19 infection, various post-illness symptoms may arise, and persistent cough is acommon complaint in traditional Chinese medicine outpatient clinics during the pandemic. The invasion of damp-heat pathogenic factors through the oral and nasal passages primarily affects the delicate lung organ, leading to lung qi dysfunction and upward rebellion of lung qi, resulting in symptoms such as cough, chest tightness, and wheezing. Apart from traditional Chinese medicine syndrome differentiation based on Zang-Fu organs or the Eight Principles, consideration must also be given to whether the lungs themselves have suffered viral infection-induced damage or structural changes. The formation of bronchiectasis is influenced by certain diseases that affect the respiratory tract's mucociliary clearance and immune function, leading to abnormal airway structure, impaired mucus clearance, and decreased lung function. In this article, we present acase study of afemale patient diagnosed with bronchiectasis after experiencing persistent cough for over six months following aconfirmed COVID-19 infection. We retrospectively review the process of combined traditional Chinese and Western medicine treatment and discuss the importance of lung function and imaging examinations.


The first to third phases of the Comprehensive Plan gradually improved the legal framework of Korean medicine and pharmaceutics (hereinafter referred to as''KMP''), established infrastructure, and laid foundation and system of policy. And many achievements in Korean medical services, Herbal medicine quality, KMP industry, KMP research and development, KMP international competitiveness have completed. The achievements in Korean medical services mainly include the establishment of the basic construction, the improvement of the scientific and credibility, the enhancement of quality and indemnificatory of Korean medical services, and the enhancement of the functions and roles of the KMP. The achievements in herbal medicine quality mainly include the improvement of the standards and regulations, the enhancement of distrubtion system of herbal medicine, the cultivation and protection of herbal preparations. The achievements in KMP industry mainly include assisting local governments to develop local KMP industry clusters, and the establishment and expansion of KMP wide-area clusters. The achievements in KMP research and development mainly include the researches of the Ministry of Health and Welfare, the Ministry of Science and ICT, Korea Institute of Oriental Medicine, and the support of KMP research centers. The achievements in KMP international competitiveness mainly include the improvement of the organization function of the ''National Institute for Korean Medicine Development'', the informationization of KMP knowledge, and the promotion of the international exchange of KMP.
The fourth phase of the Comprehensive Plan has four goals: ''Promoting the health and well-being of local areas based on KMP'', ''Improving the medical utilization system of KMP'', ''Innovating of the KMP industry'', and ''Improving the global competitiveness of KMP''. By strengthening the primary medical and public health services of Korean medicine, expanding KMP coverage, strengthening the life-cycle risk management system of Korean Pharmaceutics, strengthening the research of KMP in chronic diseases, aging-associated diseases, and emerging infectious diseases, supporting big data and artificial intelligence research and development in KMP, establishing a global network of KMP and other measures to develop Comprehensive Plan goal.
According to the results of the Comprehensive Plan, it is recommended to refer to the KMP development past budgets for Taiwan’s Chinese medicine and pharmacy (hereinafter referred to as''TMP'') development funds, establish and improve TMP statistics system, research and analyze the KMP development achievements which including KMP infrastructure (e.g. Oriental Medicine Advanced Searching Integrated System), KMP standards (e.g GAP standard cultivation techniques in medicinal crops), and special measures of KMP (e.g KMP industry cluster). And the fourth phase of the Comprehensive Plan will develop policies such as KMP home health care, premium herb, herbal medicine safety assessment and side-effect monitoring, hospital and out-of-hospital decoction room management, KMP innovative technology development projects, etc. It is recommended that research relevant results and policy to establish the medium-term and long-term plans which meets the current situation and development needs of TMP.